Edit search
Anti-infliximab antibodies are already detectable in most pa…
Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusioncycle%3A an open-label pharmacokinetic cohort study
Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusioncycle%3A an open-label pharmacokinetic cohort study
Article, Chapter
Authors: B.J.F van den
Publication: BMC Musculoskeletal Disorders, Volume:12, Page(s):12-12
Published: BioMed Central, 2011
ISSN: 1471-2474
  Full text availability for this item
Browse related articles
  Print copies at your library
  Request a copy of this item
Cite this item